✦ LIBER ✦

Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells

✍ Scribed by Engel, H; Drach, J; Keyhani, A; Jiang, S; Van, NT; Kimmel, M; Sanchez-Williams, G; Goodacre, A; Andreeff, M

Book ID: 110054153
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 713 KB
Volume: 13
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2401359

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection of minimal residual disease by

Detection of minimal residual disease by mutant p53 immunocytochemistry in acute myelogenous leukemia

✍ Kattamis, Antonios C.; Tsangaris, George Th.; Vamvoukakis, John; Moschovi, Maria 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB 👁 2 views

Molecular and cytogenetic remission in a

Molecular and cytogenetic remission in a case of subtype M4E acute myelogenous leukemia with minimal monochemotherapy: high sensitivity or spontaneous remission?

✍ Maria Paola Martelli; Roberto Latagliata; Antonio Spadea; Giuseppe Avvisati; Mar 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Quantitation of minimal residual disease

Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR

✍ Sugimoto, Takeshi; Das, Hiranmoy; Imoto, Shion; Murayama, Tohru; Gomyo, Hiroshi; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

t(8;21) is one of the common chromosomal translocations in acute myelogenous leukemia (AML). Using a recently developed real-time quantitative polymerase chain reaction (PCR) system, we analyzed the minimal residual disease (MRD) in bone marrow samples from seven AML patients with t(8;21) at differe

Long-lasting complete remission in plasm

Long-lasting complete remission in plasma cell leukemia after aggressive chemotherapy and CD34-selected autologous peripheral blood progenitor cell transplant: molecular follow-up of minimal residual disease

✍ Sica, S; Chiusolo, P; Salutari, P; Piccirillo, N; Laurenti, L; Ortu La Barbera, 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 34 KB

Impact of Cytogenetics and Marrow Remiss

Impact of Cytogenetics and Marrow Remission Status on Disease Progression in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Undergoing Allogeneic Stem Cell Transplantation

✍ E. Koca; R.M. Saliba; M. de Lima; U. Popat; P. Kebriaei; G. Rondon; W. Zhang; S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Role of minimal residual disease and chi

Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome

✍ Bernal, Teresa; Diez-Campelo, María; Godoy, Vicky; Rojas, Silvia; Colado, Enriqu 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 1011 KB